| top | |
| GLIOBLASTOMA NEWSLETTER | |
Volume 1, Number 6 - 2 October 2002 |
|
THE REFERENCES FROM THE ARTICLE
"TREATMENT OPTIONS FOR GLIOBLASTOMA AND OTHER GLIOMAS" BY BEN
WILLIAMS
(Last Updated:
September 25, 2002. Source: http://www.virtualtrials.com/williams.cfm
)
Part 1 - Reference Numbers from 1 to 20.
Medical
Research Council Brain Tumor Working Party
Randomized trial
of procarbazine, lomustine, and vincristine in the adjuvant treatment of
high-grade astrocytoma: a Medical Research Council trial
J Clin Oncol 2001 Jan 15;19(2):509-18 (Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11208845
Chamberlain
MC, Jaeckle KA
Medical
Research Council adjuvant trial in high-grade gliomas
J Clin Oncol 2001 Oct 1;19(19):3997-9 (Reference)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11579124
Full
Text article at: http://www.ncbi.nlm.nih.gov/entrez/utils/fref.fcgi?http://www.jco.org/cgi/pmidlookup?view=full&pmid=11579124
Reni M, Cozzarini C, Ferreri AJ, Ceresoli
GL, Galli L, Bianchi A, Villa E.
A
retrospective analysis of postradiation chemotherapy in 133 patients with
glioblastoma multiforme
Cancer Invest
2000;18(6):510-5 (Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10923098&dopt=Abstract
Levin
VA, Prados MR, Wara WM, Davis RL, Gutin PH, Phillips TL, Lamborn K, Wilson
CB
Radiation
therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine,
and vincristine for the treatment of anaplastic gliomas
Int J Radiat Oncol Biol Phys 1995 Apr 30;32(1):75-83 (Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7721642&dopt=Abstract
Yung WK,
Mechtler L, Gleason MJ
Intravenous
carboplatin for recurrent malignant glioma: a phase II study
J Clin Oncol 1991 May;9(5):860-4 (Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1849986&dopt=Abstract
Cloughesy TF, Black
KL, Gobin YP, Farahani K, Nelson G, Villablanca P, Kabbinavar F, Vineula F,
Wortel CH
Intra-arterial
Cereport (RMP-7) and carboplatin: a dose escalation study for recurrent
malignant gliomas
Neurosurgery
1999 Feb;44(2):270-8 (Abstract); discussion 278-9
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9932880&dopt=Abstract
Prados
MD, Schold SC, Spence AM, Berger MS, McAllister LD, Mehta MP, Gilbert MR, Fulton D, Kuhn J, Lamborn K, Rector DJ, Chang
SM
Phase
II study of paclitaxel in patients with recurrent malignant glioma
J
Clin Oncol 1996 Aug;14(8):2316-21
(Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8708723&dopt=Abstract
Raphael
M Pfeffer, Zvi Lidar, Jacob Baram, Tali Jonas, Meir Faibel, Dvora Nass, Zvi
Ram, Yael Mardor
Convection-enhanced
intra-tumoral delivery of taxol for recurrent glioblastoma. Results of a phase I
clinical study
ASCO
Proceedings, 2002 Annual Meeting,
Abstract No. 316
Source: http://www.asco.org/asco/ascoMainConstructor
/0,1003,_12|002324|00_29|00A|00_18|002002|00_19|00316,00.asp
Brem
H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, Black K, Sisti M,
Brem S, Mohr G, et al.
Placebo-controlled trial of safety and efficacy of
intraoperative controlled delivery by biodegradable polymers of chemotherapy for
recurrent gliomas. The Polymer-brain Tumor Treatment Group
Lancet 1995 Apr 22;345(8956):1008-12 (Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7723496&dopt=Abstract
Valtonen S, Timonen U, Toivanen P, Kalimo H, Kivipelto L,
Heiskanen O, Unsgaard G, Kuurne T
Interstitial
chemotherapy with carmustine-loaded polymers for high-grade gliomas: a
randomized double-blind study
Neurosurgery
1997 Jul;41(1):44-8 (Abstract); discussion 48-9
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9218294&dopt=Abstract
Subach
BR, Witham TF, Kondziolka D, Lunsford LD, Bozik M, Schiff D
Morbidity and survival after
1,3-bis(2-chloroethyl)-1-nitrosourea wafer implantation for recurrent
glioblastoma: a retrospective case-matched cohort series
Neurosurgery
1999 Jul;45(1):17-22 (Abstract); discussion 22-3
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10414561&dopt=Abstract
Yung WK, Albright RE, Olson J, Fredericks R, Fink K, Prados MD, Brada M, Spence
A, Hohl RJ, Shapiro W, Glantz M, Greenberg H, Selker RG, Vick NA, Rampling R,
Friedman H, Phillips P, Bruner J, Yue N, Osoba D, Zaknoen S, Levin VA.
A
phase II study of temozolomide vs. procarbazine in patients with glioblastoma
multiforme at first relapse
Br J
Cancer 2000 Sep;83(5):588-93
(Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10944597&dopt=Abstract
Stupp R, Dietrich PY, Ostermann
Kraljevic S, Pica A, Maillard I, Maeder P, Meuli R, Janzer R, Pizzolato G,
Miralbell R, Porchet F, Regli L, de Tribolet N, Mirimanoff RO, Leyvraz S.
Promising survival for patients with newly
diagnosed glioblastoma multiforme treated with concomitant radiation plus
temozolomide followed by adjuvant temozolomide
J Clin Oncol 2002 Mar 1;20(5):1375-82 (Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11870182&dopt=Abstract
Friedman
HS, Petros WP, Friedman AH, Schaaf
LJ, Kerby T, Lawyer J, Parry M,
Houghton PJ, Lovell S, Rasheed K, Cloughsey T, Stewart ES, Colvin OM, Provenzale
JM, McLendon RE, Bigner DD, Cokgor I, Haglund M, Rich J, Ashley D, Malczyn J,
Elfring GL, Miller LL
Irinotecan
therapy in adults with recurrent or progressive malignant glioma
J Clin Oncol 1999
May;17(5):1516-25 (Abstract)
Source:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10334539&dopt=Abstract
J
Buckner, J Reid, L
Schaaf, S Cha, K Wright, R Marks, M Wiesenfeld, A
Hatfield, J Krook, S Nair, P Schaefer, L Miller
A Phase II Trial of Irinotecan (CPT-11) in
Recurrent Glioma
ASCO Proceedings, 2000 Annual Meeting, Abstract No. 679A
Source: http://www.asco.org/asco/ascoMainConstructor
/0,1003,_12|002324|00_29|00A|00_18|002000|00_19|00201491,00.asp
Chamberlain
MC
Salvage
chemotherapy with CPT-11 for recurrent glioblastoma multiforme
J Neurooncol 2002 Jan;56(2):183-8 (Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11995820&dopt=Abstract
Bowles
AP Jr, Pantazis CG, Wansley W
Use of
verapamil to enhance the antiproliferative activity of BCNU in human glioma
cells: an in vitro and in vivo study
J
Neurosurg 1990 Aug;73(2):248-53 (Abstract)
Source:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2366081&dopt=Abstract
Belpomme
D, Gauthier S, Pujade-Lauraine E, Facchini T, Goudier MJ, Krakowski I,
Netter-Pinon G, Frenay M, Gousset C, Marie FN, Benmiloud M, Sturtz F
Verapamil
increases the survival of patients with anthracycline-resistant metastatic
breast carcinoma
Ann Oncol 2000 Nov;11(11):1471-6 (Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11142488&dopt=Abstract
Figueredo A, Arnold A, Goodyear M, Findlay B, Neville A,
Normandeau R, Jones A
Addition
of verapamil and tamoxifen to the initial chemotherapy of small cell lung
cancer. A phase I/II study
Cancer
1990 May 1;65(9):1895-902 (Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2164872&dopt=Abstract
OTHER
SUGGESTED REFERENCES ON
PCV-DEBATE, ANTICANCER VACCINATION, RADIOIMMUNOTHERAPY
Kappelle
AC, Postma TJ, Taphoorn MJ, Groeneveld
GJ, van den Bent MJ, van Groeningen
CJ, Zonnenberg BA, Sneeuw KC, Heimans JJ
PCV
chemotherapy for recurrent glioblastoma multiforme
Neurology 2001 Jan 9;56(1):118-20 (Abstract, Full Text)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11148250&dopt=Abstract
Free
Full Text article at: http://www.ncbi.nlm.nih.gov/entrez/utils/fref.fcgi?
http://www.neurology.org/cgi/pmidlookup?view=full&pmid=11148250
John H.
Sampson,
Gerald E. Archer, David M. Ashley, Herbert E. Fuchs,
Laura P. Hale, Glenn Dranoff, and Darell D. Bigner
Subcutaneous vaccination with
irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located
in the "immunologically privileged" central nervous system
PNAS Online Vol. 93, Issue 19, 10399-10404, September 17, 1996 (Abstract)
Source: http://www.pnas.org/cgi/content/abstract/93/19/10399?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=
&author1=Sampson&searchid=1028880761842_499&stored_search=&FIRSTINDEX=0
Grana C, Chinol M, Robertson C, Mazzetta C, Bartolomei M, De Cicco C,
Fiorenza M, Gatti M, Caliceti P, Paganelli G.
Pretargeted
adjuvant radioimmunotherapy with yttrium-90-biotin in malignant glioma patients:
a pilot study
Br
J Cancer 2002 Jan 21;86(2):207-12 (Clinical Study,
Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11870507&dopt=Abstract
Paganelli G, Zoboli S, Cremonesi M, Bodei L, Ferrari M, Grana C,
Bartolomei M, Orsi F, De Cicco C, Macke HR, Chinol M, de Braud F.
Receptor-mediated
radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide
Eur
J Nucl Med 2001 Apr;28(4):426-34 (Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11357492&dopt=Abstract
Paganelli G, Grana C, Chinol M, Cremonesi M, De Cicco C, De Braud F,
Robertson C, Zurrida S, Casadio C, Zoboli S, Siccardi AG, Veronesi U.
Antibody-guided
three-step therapy for high grade glioma with yttrium-90 biotin
Eur
J Nucl Med 1999 Apr;26(4):348-57 (Abstract)
Source: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10199940&dopt=Abstract